리튬 또는 발프로산으로 치료받은 양극성장애 환자의 무증상 갑상선저하증

Objectives To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods The study participants were 106 patients with DSM-IV bipolar disorders receiving planned maintenance treatment at the Mood Disorders Clinic of Seo...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Korean Society of Biological Psychiatry Vol. 20; no. 4; pp. 151 - 158
Main Authors 최현만, 장재승, 김자연, 김정현, 최정은, 하태현, 하규섭, Choi, Hyeon Man, Chang, Jae Seung, Kim, Jayoun, Kim, Jeong Hyun, Choi, Jung Eun, Ha, Tae Hyon, Ha, Kyooseob
Format Journal Article
LanguageKorean
Published 대한생물정신의학회 01.11.2013
Subjects
Online AccessGet full text
ISSN1225-8709
2005-7571

Cover

Abstract Objectives To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods The study participants were 106 patients with DSM-IV bipolar disorders receiving planned maintenance treatment at the Mood Disorders Clinic of Seoul National University Bundang Hospital (aged between 17 and 64, mean duration of follow-up = 875.65 days). Using the bipolar disorder registry, thyroid function data were analyzed to assess the frequency of and the risk factors for SCH in patients managed by lithium (n = 64) or valproic acid (n = 42) for more than 5 months. Results Overall frequencies of SCH were 20.3% (13/64) in the lithium group, 14.3% (6/42) in the valproic acid group, and between the two groups there is no difference (p = 0.43). No differences were observed in the potential risk factors for SCH between the two groups including age, sex, subtype of bipolar disorder, baseline TSH, and concomitant antipsychotic use. In cases with SCH, thyroid-stimulating hormone (TSH) showed a tendency to increase at 3 month after the initiation of lithium or valproic acid. A gradual increase in the number of patients showing SCH was found within the first 3 years of medication. Conclusions With regular monitoring and careful assessment, there was no difference in the risk of SCH between lithium and valproic acid maintenance. The risk of mood stabilizer-associated SCH may gradually increase within 3 years following the commencement of medication, thereby mandating close monitoring for the first 3 years of treatment. Further studies with large sample size would be needed to confirm these findings.
AbstractList Objectives To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods The study participants were 106 patients with DSM-IV bipolar disorders receiving planned maintenance treatment at the Mood Disorders Clinic of Seoul National University Bundang Hospital (aged between 17 and 64, mean duration of follow-up = 875.65 days). Using the bipolar disorder registry, thyroid function data were analyzed to assess the frequency of and the risk factors for SCH in patients managed by lithium (n = 64) or valproic acid (n = 42) for more than 5 months. Results Overall frequencies of SCH were 20.3% (13/64) in the lithium group, 14.3% (6/42) in the valproic acid group, and between the two groups there is no difference (p = 0.43). No differences were observed in the potential risk factors for SCH between the two groups including age, sex, subtype of bipolar disorder, baseline TSH, and concomitant antipsychotic use. In cases with SCH, thyroid-stimulating hormone (TSH) showed a tendency to increase at 3 month after the initiation of lithium or valproic acid. A gradual increase in the number of patients showing SCH was found within the first 3 years of medication. Conclusions With regular monitoring and careful assessment, there was no difference in the risk of SCH between lithium and valproic acid maintenance. The risk of mood stabilizer-associated SCH may gradually increase within 3 years following the commencement of medication, thereby mandating close monitoring for the first 3 years of treatment. Further studies with large sample size would be needed to confirm these findings.
Objectives: To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods: The study participants were 106 patients with DSM-IV bipolar disorders receiving planned maintenance treatment at the Mood Disorders Clinic of Seoul National University Bundang Hospital (aged between 17 and 64, mean duration of follow-up = 875.65 days). Using the bipolar disorder registry, thyroid function data were analyzed to assess the frequency of and the risk factors for SCH in patients managed by lithium (n = 64) or valproic acid (n = 42) for more than 5 months. Results: Overall frequencies of SCH were 20.3% (13/64) in the lithium group, 14.3% (6/42) in the valproic acid group, and between the two groups there is no difference (p = 0.43). No differences were observed in the potential risk factors for SCH between the two groups including age, sex, subtype of bipolar disorder, baseline TSH, and concomitant antipsychotic use. In cases with SCH, thyroid-stimulating hormone (TSH) showed a tendency to increase at 3 month after the initiation of lithium or valproic acid. A gradual increase in the number of patients showing SCH was found within the first 3 years of medication. Conclusions: With regular monitoring and careful assessment, there was no difference in the risk of SCH between lithium and valproic acid maintenance. The risk of mood stabilizer-associated SCH may gradually increase within 3 years following the commencement of medication, thereby mandating close monitoring for the first 3 years of treatment. Further studies with large sample size would be needed to confirm these findings. KCI Citation Count: 0
Author Choi, Hyeon Man
김자연
김정현
Chang, Jae Seung
Ha, Tae Hyon
Ha, Kyooseob
Choi, Jung Eun
장재승
최현만
하태현
Kim, Jeong Hyun
최정은
Kim, Jayoun
하규섭
Author_xml – sequence: 1
  fullname: 최현만
– sequence: 2
  fullname: 장재승
– sequence: 3
  fullname: 김자연
– sequence: 4
  fullname: 김정현
– sequence: 5
  fullname: 최정은
– sequence: 6
  fullname: 하태현
– sequence: 7
  fullname: 하규섭
– sequence: 8
  fullname: Choi, Hyeon Man
– sequence: 9
  fullname: Chang, Jae Seung
– sequence: 10
  fullname: Kim, Jayoun
– sequence: 11
  fullname: Kim, Jeong Hyun
– sequence: 12
  fullname: Choi, Jung Eun
– sequence: 13
  fullname: Ha, Tae Hyon
– sequence: 14
  fullname: Ha, Kyooseob
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001823693$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNotkMtKw0AARQepYK39h2wEN4F5JJnMshQf1UJBuw9NJiMhJYXGD6jaVXHRQisR01IRu-oigiAFv6gz-QeDdXUul8Nd3ENQinqRvwfKGEJTpyZFJVBGGJu6TSE7ANU4DlxoEkItxlgZcLla56O1JpOxHE01maX5dCjfUvWQqfSnCJraJPL9SWavaj7Q1PNk-71Rw0-1-FCzpZa_JGoxVvNEk-svtZqrx3ttm00KqOFSLQf5LCnaI7AvOt3Yr_6zAm7OTtv1C73ZOm_Ua009tIit2x7ChgGhMIQvPNNjGCEukMWoxw1PIAQ5oS71TMZ8wU2fusJHhssNzi2LMFIBJ7vVqC-c0AucXif4423PCftO7brdcKhNmWEX6vFODYP4LnAiHnedy9pVC0NEIC5esxG0bEx-AbdzgJs
ContentType Journal Article
DBID JDI
ACYCR
DEWEY 616.89
DatabaseName KoreaScience
Korean Citation Index
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Subclinical Hypothyroidism in Patients with Bipolar Disorders Managed by Lithium or Valproic Acid
EISSN 2005-7571
EndPage 158
ExternalDocumentID oai_kci_go_kr_ARTI_787948
JAKO201302757810682
GroupedDBID 8JR
ALMA_UNASSIGNED_HOLDINGS
JDI
ACYCR
ID FETCH-LOGICAL-k638-8c124400f4fefc5c9211df1697cd4cf110d37b7c599efd5e7bfe14bd4dd66393
ISSN 1225-8709
IngestDate Fri Nov 17 19:22:13 EST 2023
Fri Dec 22 12:03:28 EST 2023
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k638-8c124400f4fefc5c9211df1697cd4cf110d37b7c599efd5e7bfe14bd4dd66393
Notes KISTI1.1003/JNL.JAKO201302757810682
G704-001487.2013.20.4.004
OpenAccessLink http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO201302757810682&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_787948
kisti_ndsl_JAKO201302757810682
PublicationCentury 2000
PublicationDate 2013-11
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11
PublicationDecade 2010
PublicationTitle Journal of the Korean Society of Biological Psychiatry
PublicationTitleAlternate Korean journal of biological psychiatry
PublicationYear 2013
Publisher 대한생물정신의학회
Publisher_xml – name: 대한생물정신의학회
SSID ssib053376999
ssj0068802
ssib012146169
ssib036278676
ssib005568764
Score 1.8507645
Snippet Objectives To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods The...
Objectives: To investigate the pattern of subclinical hypothyroidism (SCH) in patients with bipolar disorders managed by lithium or valproic acid. Methods: The...
SourceID nrf
kisti
SourceType Open Website
Open Access Repository
StartPage 151
SubjectTerms 정신과학
Title 리튬 또는 발프로산으로 치료받은 양극성장애 환자의 무증상 갑상선저하증
URI http://click.ndsl.kr/servlet/LinkingDetailView?cn=JAKO201302757810682&dbt=JAKO&org_code=O481&site_code=SS1481&service_code=01
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001823693
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 생물정신의학, 2013, 20(4), , pp.151-158
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtB2OXsU_WfRQPplPJsGz5Q0fbTelaug3WQW_BsexSMhLI2stO3dZT2aGFdmT0g46xnnrIYDAK-4tq5X_YkyIn7mih28V5fnp6kt6T9X5KnmKEnnAnS3iamhXmwt6EshieuZjEFTtJqJ1ZWb1_Km3-uTvzms4uOosjo7ulrKXVlfrT5N2550r-x6vAA7_KU7L_4NmBUmAADf6FK3gYrpfyMa6GOHBxEOHqFPYDICYli_mYmZIAFqOKFZqYKSkG2JGqekRxIuxbshQIuA2jQdGkZIVMKpMsG_tRoShU0tCiqYSYixnB1QCHnqwgVVIcElVUxYGjCAcHUho60FepypipNTFf9RIGElLJgkEBV2qCdsmkUm6qVjRLtxIoBXD1TaXb0bpV_Qtwt0Tac622_AWiSFkFbv-dnGrGvjyTAC5nozKFU1jQLyw4jcOoLDIcbVX5JJIOCNlQRN6prpZHD0YzzxWBYcGAihbLX88QW59TLB4o5eyoZIVIW0pasW_XqKQSikJtO2X8ohZTRACqSrEKlmIIZiYrxR-i_7031Xf-MMwXqQ1_Rf8z_zPeSJZrS61ao12D3dSzGizmjPqjaNQmEEKuBOFUOD1cvB0XIulgMSfqDfHuABsDMPJ8V2LdPixyIVCo1IOi17AblFukZQB1zXZWAnULN9B1PSuMoP9o3UQjjdYtdHVe55vcRjw_Ou5tHBt5ZzPf2Dby7l5vez3_uic-dMXebyAMcdLJv33Ku7tif80Qn7dOf52I9R_i4LvYOTR6XzriYFPsd4z8-Kc42hcf3xun3S34EOuH4nCtt9MB7h30arq6EM1U9HtJKg2IVhU_kZjYNDOapVniJMwihGcwdC_hNMkAT3Pbq3uJw1iacSf16llKaJ1TzgHeM_suGmu2muk9ZMSeTazMtDmPGU1oHAM8gXWT8QyqcMseRxPKRLUmf_umNhvMvbB0ooHnE7CoNY4eg-2U2y503_1LyDxA14Zz9yEaW2mvpo8AbK_UJ7Tb_wAdpbgm
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EB%A6%AC%ED%8A%AC+%EB%98%90%EB%8A%94+%EB%B0%9C%ED%94%84%EB%A1%9C%EC%82%B0%EC%9C%BC%EB%A1%9C+%EC%B9%98%EB%A3%8C%EB%B0%9B%EC%9D%80+%EC%96%91%EA%B7%B9%EC%84%B1%EC%9E%A5%EC%95%A0+%ED%99%98%EC%9E%90%EC%9D%98+%EB%AC%B4%EC%A6%9D%EC%83%81+%EA%B0%91%EC%83%81%EC%84%A0%EC%A0%80%ED%95%98%EC%A6%9D&rft.jtitle=Journal+of+the+Korean+Society+of+Biological+Psychiatry&rft.au=%EC%B5%9C%ED%98%84%EB%AF%BC&rft.au=%EC%9E%A5%EC%9E%AC%EC%8A%B9&rft.au=%EA%B9%80%EC%9E%90%EC%97%B0&rft.au=%EA%B9%80%EC%A0%95%ED%98%84&rft.date=2013-11-01&rft.pub=%EB%8C%80%ED%95%9C%EC%83%9D%EB%AC%BC%EC%A0%95%EC%8B%A0%EC%9D%98%ED%95%99%ED%9A%8C&rft.issn=1225-8709&rft.spage=151&rft.epage=158&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_787948
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1225-8709&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1225-8709&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1225-8709&client=summon